Cell Source, Inc. (CLCS)
OTCMKTS · Delayed Price · Currency is USD
0.4000
-0.0610 (-13.23%)
Jul 25, 2025, 1:50 PM EDT
Cell Source Market Cap
Cell Source has a market cap or net worth of $19.39 million as of July 25, 2025. Its market cap has increased by 1.39% in one year.
Market Cap
19.39M
Enterprise Value
29.46M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.40
Market Cap Chart
Since July 1, 2014, Cell Source's market cap has decreased from 36.03M to 19.39M, a decrease of -46.19%. That is a compound annual growth rate of -5.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 25, 2025 | 19.39M | 27.04% |
| Dec 31, 2024 | 15.26M | -14.98% |
| Dec 27, 2023 | 17.95M | -40.09% |
| Dec 29, 2022 | 29.96M | -30.67% |
| Dec 31, 2021 | 43.22M | -32.39% |
| Dec 31, 2020 | 63.92M | 119.45% |
| Dec 27, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 20, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 23, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo, Inc. | 1.81B |
| Veradigm | 789.71M |
| Nika Pharmaceuticals | 708.22M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 590.95M |
| Glass House Brands | 435.80M |
| Northwest Biotherapeutics | 377.68M |
| CytoDyn | 371.09M |